Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
MARCIA BELVIN Insider Profile
4 Followers
MARCIA BELVIN, SVP, Chief Scientific Officer at CytomX Therapeutics, holds 168.58K shares in CytomX Therapeutics (Ticker: CTMX). Most recently, MARCIA BELVIN Sold $12,795 shares of CytomX Therapeutics on Mar 21, 2024 for an estimated value of 26.61K.
MARCIA BELVIN CytomX Therapeutics (CTMX)SVP, Chief Scientific Officer
CytomX Therapeutics (CTMX)
SVP, Chief Scientific Officer
Ranked #96,187 out of 98,743 Corporate Insiders
Profitable Transactions
0 out of 3 Profitable Transactions
Average Return
-183.70%
Average return per transaction
Time Frame
Compare to
Insider Roles
SVP, Chief Scientific Officer
Roles that MARCIA BELVIN holds in companies
Most Profitable Insider Trade
The most profitable trade made by MARCIA BELVIN
MARCIA BELVIN's Trading History
List of latest transactions for each holding click on a transaction to see MARCIA BELVIN's performance on stock
You May Also Like
MARCIA BELVIN insider profile FAQ
What is the percentage of profitable transactions made by MARCIA BELVIN?
The percentage of profitable transactions made by MARCIA BELVIN is 0%.
What is the average return per transaction made by MARCIA BELVIN?
The average return per transaction made by MARCIA BELVIN is -183.70%.
What stocks does MARCIA BELVIN hold?
MARCIA BELVIN holds: CTMX stocks.
What was MARCIA BELVIN’s latest transaction?
MARCIA BELVIN latest transaction was an Informative Sell of $26.61K.
What was MARCIA BELVIN's most profitable transaction?
MARCIA BELVIN’s most profitable transaction was an Informative Sell of CTMX stock on March 21, 2024. The return on the trade was -97.70%.
What is MARCIA BELVIN's role in CytomX Therapeutics?
MARCIA BELVIN's role in CytomX Therapeutics is SVP, Chief Scientific Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.